Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | 0.00% | 0.00% | +42.86% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 48.85 | 25.12 | 4.893 | 6.73 | 3.687 | 0.8899 |
Enterprise Value (EV) 1 | 139.1 | 123.2 | 104.3 | 98.11 | 103.5 | 112.5 |
P/E ratio | -2.9 x | -1.15 x | -0.26 x | 0.41 x | -0.15 x | -0.03 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.52 x | 1.51 x | 0.48 x | 0.44 x | 0.34 x | 0.08 x |
EV / Revenue | 7.18 x | 7.43 x | 10.3 x | 6.42 x | 9.52 x | 10.3 x |
EV / EBITDA | -31.3 x | -27.4 x | -19.9 x | -187 x | 1,186 x | 103 x |
EV / FCF | -51.5 x | 24.5 x | 66.8 x | -3.87 x | 29 x | 29.4 x |
FCF Yield | -1.94% | 4.07% | 1.5% | -25.8% | 3.45% | 3.4% |
Price to Book | -0.6 x | -0.27 x | -0.05 x | -0.05 x | -0.03 x | -0 x |
Nbr of stocks (in thousands) | 37,890 | 38,394 | 37,673 | 38,394 | 38,394 | 38,394 |
Reference price 2 | 1.289 | 0.6543 | 0.1299 | 0.1753 | 0.0960 | 0.0232 |
Announcement Date | 4/2/18 | 4/1/19 | 6/5/20 | 3/31/21 | 3/31/22 | 4/3/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 19.39 | 16.58 | 10.15 | 15.29 | 10.88 | 10.92 |
EBITDA 1 | -4.44 | -4.494 | -5.231 | -0.5243 | 0.0873 | 1.088 |
EBIT 1 | -8.085 | -7.826 | -7.973 | -2.034 | -1.197 | -0.1645 |
Operating Margin | -41.7% | -47.2% | -78.55% | -13.3% | -11% | -1.51% |
Earnings before Tax (EBT) 1 | -17.57 | -26.46 | -25.02 | 28.08 | -23.87 | -33.31 |
Net income 1 | -16.83 | -21.58 | -19.29 | 16.53 | -23.7 | -33.05 |
Net margin | -86.82% | -130.16% | -190.06% | 108.09% | -217.94% | -302.61% |
EPS 2 | -0.4439 | -0.5700 | -0.5025 | 0.4300 | -0.6200 | -0.8608 |
Free Cash Flow 1 | -2.7 | 5.019 | 1.561 | -25.34 | 3.567 | 3.826 |
FCF margin | -13.93% | 30.26% | 15.38% | -165.71% | 32.8% | 35.03% |
FCF Conversion (EBITDA) | - | - | - | - | 4,086.43% | 351.8% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/2/18 | 4/1/19 | 6/5/20 | 3/31/21 | 3/31/22 | 4/3/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 90.3 | 98.1 | 99.4 | 91.4 | 99.9 | 112 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -20.34 x | -21.82 x | -19.01 x | -174.3 x | 1,144 x | 102.6 x |
Free Cash Flow 1 | -2.7 | 5.02 | 1.56 | -25.3 | 3.57 | 3.83 |
ROE (net income / shareholders' equity) | 19.9% | 25.8% | 19.9% | -21.7% | 17.6% | 20.3% |
ROA (Net income/ Total Assets) | -9.72% | -10.5% | -12.4% | -4.1% | -2.99% | -0.43% |
Assets 1 | 173.2 | 204.7 | 156 | -403.6 | 792.3 | 7,637 |
Book Value Per Share 2 | -2.150 | -2.390 | -2.790 | -3.220 | -3.830 | -4.680 |
Cash Flow per Share 2 | 0.0200 | 0.0400 | 0.0100 | 0.0100 | 0.0100 | 0.0100 |
Capex 1 | 0.34 | 0.66 | 0.14 | 0.01 | 0.13 | 0.01 |
Capex / Sales | 1.75% | 3.95% | 1.43% | 0.04% | 1.17% | 0.12% |
Announcement Date | 4/2/18 | 4/1/19 | 6/5/20 | 3/31/21 | 3/31/22 | 4/3/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+4.27% | 29.77B | |
+13.39% | 11.83B | |
+14.05% | 5.15B | |
+13.93% | 4.21B | |
-15.09% | 3.48B | |
-2.50% | 3.14B | |
+4.91% | 3.11B | |
+27.19% | 2.79B | |
-6.93% | 2.33B |
- Stock Market
- Equities
- GLGLF Stock
- GLG Stock
- Financials GLG Life Tech Corporation